期刊文献+

双膦酸盐类药治疗恶性肿瘤高钙血症临床观察 被引量:10

Clinical evaluation of bisphosphonates for the treatment of tumor-induced hypercalcemia
下载PDF
导出
摘要 目的 观察双膦酸盐类治疗恶性肿瘤高钙血症的疗效。方法 对 8例恶性肿瘤高钙血症患者应用双膦酸盐类治疗 11次 ,所用双膦酸盐类有羟乙膦酸二钠、氯屈膦酸二钠、帕米膦酸二钠。结果 用药后血离子钙浓度均有下降 ,CR+PR者达 90 .9%。血钙维持正常时间为 1~ 30 0天 ,中位时间 14天 ,生存期 1.5~ 9月 ,平均生存期 3.5月。高钙血症相关症状消失或减轻。未见明显毒副反应。结论 双膦酸盐类对恶性高钙血症有较好疗效 ,但维持时间短暂 ,应联合其它抗肿瘤措施以延长生命。
机构地区 解放军第
出处 《实用肿瘤杂志》 CAS 北大核心 2001年第6期418-420,共3页 Journal of Practical Oncology
  • 相关文献

参考文献7

  • 1[1]Flores JF,Rude RK,Chapman RA,et al.Evaluation of a 24-h infusion of etidronate disoclium for the treatment of hypercalcemia of malignancy [J].Cancer,1994,73 (10):2527-2534.
  • 2[2]Budagr AA,Zysset E,Jenzer A,et al.Effects of treatment of malignancy-associated hypercalcemia on serum parathyroid hormone-related protein [J].J Bone Miner Res,1994,9(4):521-526.
  • 3[3]Chisholm MA,Mulloy AL,Taylor AT.Acute management of cancer-related hypercalcemia [J].Ann.Pharmacother,1996,30(5):507-513.
  • 4[4]Parohit OP,Radstone CR,Anthony C,et al.A randomised double-blind comparison of intravenous Pamidronate and clodronate in the hypercalcemia of malignancy [J].BR J Cancer,1995,72(5):1289-1293.
  • 5[5]Singer FR,Ritch PS,Lad TE,et al.Treatment of hypercalcemia of malignancy with intravenous etidronate.A Controlled,multicenter study [J].Arch Intern Med,1991,151 (3):471-476.
  • 6[6]Rotstein S,Glas U,Eriksson M,et al.Intravenous clodronate for the treatment of hypercalcemia in breast cancer patients with bone metastases-A prospective randomised placebo-controlled multicentre study [J].Eur J Cancer,1992,28A(4/5):890-893.
  • 7[7]Gurney H,Grill V.Martin TJ.Parathyroid hormonerelated protein and response to pamidronate in tumorinduced hypercalcemia [J].Lancet,1993,341(8861):1611-1613.

同被引文献90

引证文献10

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部